Cargando…

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a chronic neurodegenerative rare disease that affects motor neurons in the brain, brainstem, and spinal cord, resulting in progressive weakness and atrophy of voluntary skeletal muscles. Although much has been achieved in understanding the disease p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albanese, Alberto, Ludolph, Albert Christian, McDermott, Christopher J., Corcia, Philippe, Van Damme, Philip, Van den Berg, Leonard H., Hardiman, Orla, Rinaldi, Gilberto, Vanacore, Nicola, Dickie, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552801/ https://www.ncbi.nlm.nih.gov/pubmed/36237618 http://dx.doi.org/10.3389/fneur.2022.1009113

Ejemplares similares

A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
por: Lombardo, Flavia L., et al.
Publicado: (2023)

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015)

Tauroursodeoxycholic Acid (TUDCA)—Lipid Interactions and Antioxidant Properties of TUDCA Studied in Model of Photoreceptor Membranes
por: Sabat, Michał J., et al.
Publicado: (2021)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Informal Caregivers in Amyotrophic Lateral Sclerosis: A Multi-Centre, Exploratory Study of Burden and Difficulties
por: Conroy, Éilís, et al.
Publicado: (2021)

Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021)

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
por: Al-Chalabi, Ammar, et al.
Publicado: (2019)

Connectome‐Based Propagation Model in Amyotrophic Lateral Sclerosis
por: Meier, Jil M., et al.
Publicado: (2020)

Tauroursodeoxycholic Acid (TUDCA) Protects Photoreceptors from Cell Death after Experimental Retinal Detachment
por: Mantopoulos, Dimosthenis, et al.
Publicado: (2011)

Genetic variability in sporadic amyotrophic lateral sclerosis
por: Van Daele, Sien Hilde, et al.
Publicado: (2023)

Tauroursodeoxycholic acid (TUDCA) alleviates endoplasmic reticulum stress of nuclear donor cells under serum starvation
por: Zhang, Ying, et al.
Publicado: (2018)

Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress
por: Rani, Shilpa, et al.
Publicado: (2017)

Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis
por: Dekker, Annelot M., et al.
Publicado: (2019)

Burden and benefit—A mixed methods study of informal Amyotrophic Lateral Sclerosis caregivers in Ireland and the Netherlands
por: Kennedy, Polly, et al.
Publicado: (2022)

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia
por: McLaughlin, Russell L., et al.
Publicado: (2017)

Tauroursodeoxycholic acid (TUDCA) inhibits influenza A viral infection by disrupting viral proton channel M2
por: Li, Ning, et al.
Publicado: (2019)

Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics
por: Schuster, Christina, et al.
Publicado: (2017)

Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
por: Corcia, Philippe, et al.
Publicado: (2012)

Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm
por: Elamin, Marwa, et al.
Publicado: (2015)

The Effect of Tauroursodeoxycholic Acid (TUDCA) Treatment on Pregnancy Outcomes and Vascular Function in a Rat Model of Advanced Maternal Age
por: Pasha, Mazhar, et al.
Publicado: (2022)

Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study
por: Zucchi, Elisabetta, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis: a clinical review
por: Masrori, P., et al.
Publicado: (2020)

Polyhexamethyleneguanidine Phosphate-Induced Cytotoxicity in Liver Cells Is Alleviated by Tauroursodeoxycholic Acid (TUDCA) via a Reduction in Endoplasmic Reticulum Stress
por: Kim, Sou Hyun, et al.
Publicado: (2019)

The effect of tauroursodeoxycholic Acid (TUDCA) treatment on placental endoplasmic reticulum (ER) stress in a rat model of advanced maternal age
por: Pasha, Mazhar, et al.
Publicado: (2023)

Modelling amyotrophic lateral sclerosis: progress and possibilities
por: Van Damme, Philip, et al.
Publicado: (2017)

Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis
por: Naumann, Marcel, et al.
Publicado: (2019)

Cox regression and survival analysis from the tauro-urso-deoxycholic trial in amyotrophic lateral sclerosis
por: Reggiardo, Giorgio, et al.
Publicado: (2023)

Current view and perspectives in amyotrophic lateral sclerosis
por: Mathis, Stéphane, et al.
Publicado: (2017)

Cognitive and neuropsychiatric endophenotypes in amyotrophic lateral sclerosis
por: Costello, Emmet, et al.
Publicado: (2023)

Protein aggregation in amyotrophic lateral sclerosis
por: Blokhuis, Anna M., et al.
Publicado: (2013)

Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learning
por: Antoniadi, Anna Markella, et al.
Publicado: (2021)

Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
por: Barberio, Julie, et al.
Publicado: (2023)

Non-invasive ventilation in amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2019)

Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns
por: Bede, Peter, et al.
Publicado: (2017)

SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed
por: Iacoangeli, Alfredo, et al.
Publicado: (2021)

Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study
por: Bede, Peter, et al.
Publicado: (2019)

Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis
por: Galvin, Miriam, et al.
Publicado: (2018)

Measurement of Social Cognition in Amyotrophic Lateral Sclerosis: A Population Based Study
por: Burke, Tom, et al.
Publicado: (2016)

Resting-state EEG reveals four subphenotypes of amyotrophic lateral sclerosis
por: Dukic, Stefan, et al.
Publicado: (2021)

The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis
por: Salmon, Kristiana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5seq3aivaff16q6q0tf4a2m3em